Maravai LifeSciences
MRVI
MRVI
184 hedge funds and large institutions have $292M invested in Maravai LifeSciences in 2025 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 61 increasing their positions, 51 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 185 → 184 (-1)
7.14% less ownership
Funds ownership: 99.29% → 92.15% (-7.1%)
62% less capital invested
Capital invested by funds: $769M → $292M (-$477M)
Holders
184
Holding in Top 10
3
Calls
$1.82M
Puts
$1.49M
Top Buyers
| 1 | +$16.5M | |
| 2 | +$5.73M | |
| 3 | +$4.47M | |
| 4 |
Two Sigma Investments
New York
|
+$2.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.32M |
Top Sellers
| 1 | -$29M | |
| 2 | -$16.3M | |
| 3 | -$12.2M | |
| 4 |
BAMCO Inc
New York
|
-$12M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$9.76M |